EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE

EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE was reported 124 times

These side effects are most commonly reported by patients taking EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 20
1 OFF LABEL USE 11
2 FATIGUE 10
3 DIARRHOEA 7
4 HEADACHE 6
5 NAUSEA 6
6 VOMITING 6
7 WEIGHT DECREASED 6
8 DIZZINESS 5
9 DRUG INEFFECTIVE 5
10 GLYCOSYLATED HAEMOGLOBIN INCREASED 5
11 DECREASED APPETITE 4
12 DYSPNOEA 4
13 IMPAIRED GASTRIC EMPTYING 4
14 PRODUCT PHYSICAL ISSUE 4
15 ABDOMINAL PAIN UPPER 3
16 ARTERIAL OCCLUSIVE DISEASE 3
17 ASTHENIA 3
18 CATHETERISATION CARDIAC 3
19 DEATH 3
20 EXTRA DOSE ADMINISTERED 3
21 FALL 3
22 HAEMORRHAGE 3
23 PRESCRIBED UNDERDOSE 3
24 PRODUCT ODOUR ABNORMAL 3
25 PRODUCT USE COMPLAINT 3
26 RASH 3
27 THERAPEUTIC RESPONSE UNEXPECTED 3
28 ABDOMINAL DISTENSION 2
29 ABDOMINAL PAIN 2
30 ARTHRALGIA 2
31 BLOOD GLUCOSE ABNORMAL 2
32 BLOOD PRESSURE INCREASED 2
33 CHEST PAIN 2
34 CONDITION AGGRAVATED 2
35 COUGH 2
36 DYSPHAGIA 2
37 EUGLYCAEMIC DIABETIC KETOACIDOSIS 2
38 EXPIRED PRODUCT ADMINISTERED 2
39 FOURNIER^S GANGRENE 2
40 FUNGAL INFECTION 2
41 GASTROINTESTINAL DISORDER 2
42 HEART RATE INCREASED 2
43 ILLNESS 2
44 INCREASED APPETITE 2
45 INFECTION 2
46 INSOMNIA 2
47 LACTIC ACIDOSIS 2
48 METABOLIC ACIDOSIS 2
49 PALPITATIONS 2
50 POLLAKIURIA 2
51 PRODUCT DOSE OMISSION ISSUE 2
52 PSORIASIS 2
53 PYREXIA 2
54 URINARY TRACT INFECTION 2
55 VISION BLURRED 2
56 WHITE BLOOD CELL COUNT INCREASED 2
57 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
58 ABDOMINAL DISCOMFORT 1
59 ABSCESS 1
60 ACUTE KIDNEY INJURY 1
61 ADVERSE DRUG REACTION 1
62 AMNESIA 1
63 ANAEMIA 1
64 ANXIETY 1
65 ARRHYTHMIA 1
66 ARTHROPOD BITE 1
67 BLOOD GLUCOSE FLUCTUATION 1
68 BLOOD TRIGLYCERIDES DECREASED 1
69 BLOOD TRIGLYCERIDES INCREASED 1
70 CEREBROVASCULAR ACCIDENT 1
71 CHOKING 1
72 CHOLELITHIASIS 1
73 CONCUSSION 1
74 CONTUSION 1
75 CORONAVIRUS TEST POSITIVE 1
76 COVID-19 1
77 DEMENTIA 1
78 DEPRESSED MOOD 1
79 DEPRESSION 1
80 DERMATITIS 1
81 DIABETES MELLITUS 1
82 DIABETIC KETOACIDOSIS 1
83 DIALYSIS 1
84 DISCOLOURED VOMIT 1
85 DISCOMFORT 1
86 DIVERTICULITIS 1
87 DRUG HYPERSENSITIVITY 1
88 DYSPEPSIA 1
89 ENERGY INCREASED 1
90 EYE IRRITATION 1
91 FACE OEDEMA 1
92 FAECES PALE 1
93 FLATULENCE 1
94 FOOT OPERATION 1
95 GAIT DISTURBANCE 1
96 GASTRIC DISORDER 1
97 GASTRITIS 1
98 GASTROOESOPHAGEAL REFLUX DISEASE 1
99 GENITAL RASH 1
100 GLOMERULAR FILTRATION RATE DECREASED 1
101 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1
102 HAEMATOCHEZIA 1
103 HAEMATURIA 1
104 HEAT STROKE 1
105 HERPES ZOSTER 1
106 HIP FRACTURE 1
107 HOT FLUSH 1
108 HYPERSENSITIVITY 1
109 INFECTED BITE 1
110 INTENTIONAL PRODUCT MISUSE 1
111 INTENTIONAL PRODUCT USE ISSUE 1
112 INTERVERTEBRAL DISC PROTRUSION 1
113 JOINT INJURY 1
114 KIDNEY INFECTION 1
115 KNEE ARTHROPLASTY 1
116 LIGAMENT SPRAIN 1
117 LIMB INJURY 1
118 LIP SWELLING 1
119 LOSS OF CONSCIOUSNESS 1
120 MEMORY IMPAIRMENT 1
121 MOBILITY DECREASED 1
122 MOUTH INJURY 1
123 MUSCLE SPASMS 1
124 MYALGIA 1
125 MYELITIS 1
126 MYOCARDIAL INFARCTION 1
127 NASAL CONGESTION 1
128 NASOPHARYNGITIS 1
129 NECK INJURY 1
130 NECK MASS 1
131 OCULAR DISCOMFORT 1
132 OESOPHAGEAL STENOSIS 1
133 OESOPHAGITIS 1
134 ORAL SURGERY 1
135 PAIN 1
136 PAIN IN EXTREMITY 1
137 PANCREATITIS 1
138 PANCREATITIS ACUTE 1
139 PANCREATITIS RELAPSING 1
140 PERIPHERAL SWELLING 1
141 PLATELET COUNT DECREASED 1
142 PRODUCT DISPENSING ERROR 1
143 PRODUCT DOSE OMISSION IN ERROR 1
144 PRODUCT LABEL ISSUE 1
145 PRODUCT RESIDUE PRESENT 1
146 PRODUCT SELECTION ERROR 1
147 PRODUCT USE IN UNAPPROVED INDICATION 1
148 PRURITUS 1
149 PSORIATIC ARTHROPATHY 1
150 RENAL DISORDER 1
151 RENAL INJURY 1
152 RETCHING 1
153 RHABDOMYOLYSIS 1
154 SOMNOLENCE 1
155 TOOTH DISORDER 1
156 TYPE 2 DIABETES MELLITUS 1
157 UNRESPONSIVE TO STIMULI 1
158 URINARY HESITATION 1
159 URINARY RETENTION 1
160 URINE KETONE BODY PRESENT 1
161 URTICARIA 1
162 VACCINATION COMPLICATION 1
163 WEIGHT INCREASED 1
164 WRONG DOSE 1
165 WRONG PRODUCT ADMINISTERED 1